0001104659-23-044168.txt : 20230411 0001104659-23-044168.hdr.sgml : 20230411 20230411191854 ACCESSION NUMBER: 0001104659-23-044168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230410 FILED AS OF DATE: 20230411 DATE AS OF CHANGE: 20230411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SELICK HAROLD E CENTRAL INDEX KEY: 0001287233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37852 FILM NUMBER: 23814397 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc CENTRAL INDEX KEY: 0001377121 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980505495 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 BUSINESS PHONE: (510) 474-0170 MAIL ADDRESS: STREET 1: 7707 GATEWAY BLVD., SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560-1160 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Therapeutics Inc DATE OF NAME CHANGE: 20130605 FORMER COMPANY: FORMER CONFORMED NAME: Protagonist Inc DATE OF NAME CHANGE: 20061002 4 1 tm2312473-1_4seq.xml OWNERSHIP DOCUMENT X0407 4 2023-04-10 0 0001377121 Protagonist Therapeutics, Inc PTGX 0001287233 SELICK HAROLD E C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 1 0 0 0 0 Common Stock 2023-04-10 4 M 0 6196 0.87 A 21506 D Stock Option (right to buy) 0.87 2023-04-10 4 M 0 6196 0.00 D 2023-09-26 Common Stock 6196 0 D The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date. The stock option is vested in full. /s/ Asif Ali, Attorney-in-Fact for Harold E. Selick 2023-04-11